crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …

reference pricing system in off-patent markets, and risk-sharing schemes in patent-protected markets. By taking into account … price for off-patent markets can contribute in promoting innovation. Finally, in the fourth chapter, the modeling of risk …